Breaking News Instant updates and real-time market news.

NYT

New York Times

$23.45

0.3 (1.30%)

, EXPE

Expedia

$133.73

-0.77 (-0.57%)

17:08
09/21/18
09/21
17:08
09/21/18
17:08

Expedia president Bhutani joins New York Times board

The New York Times Company (NYT) announced today that Aman Bhutani, President of the Brand Expedia Group (EXPE) at Expedia Group, Inc., has been appointed to its Board of Directors. In his present role at Expedia, which he has held since 2015, Mr. Bhutani runs all global business operations of the Brand Expedia Group including the Expedia brand globally and a set of regional brands including Travelocity, Orbitz, Cheaptickets, eBookers and Wotif. Prior to this role, he was Brand Expedia Group's chief technology officer and senior vice president of worldwide engineering, where he was well-known for having established a data-driven culture, based in the scientific method, among the group's global technology team. He's an eight year veteran of Expedia Group, Inc.

NYT

New York Times

$23.45

0.3 (1.30%)

EXPE

Expedia

$133.73

-0.77 (-0.57%)

NYT New York Times
$23.45

0.3 (1.30%)

04/30/18
JPMS
04/30/18
UPGRADE
Target $27
JPMS
Overweight
New York Times upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Alexia Quadrani upgraded New York Times to Overweight and raised her price target for the shares to $27 from $25. The analyst believes digital demand will likely drive further "outsized growth" for New York Times. Further, she expects the company's earnings growth to accelerate in early 2019.
04/30/18
04/30/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Altria Group (MO) upgraded to Outperform from Sector Perform at RBC Capital with analyst Nik Modi saying while his concerns around the macro backdrop and fundamentals persist, the current valuation of 13-times forward PE is attractive relative to the broader Consumer Packaged Goods category given the company's potential catalysts of more dividend increases tracking higher interest rates and the FDA approval process for IQOS electronic cigarettes. 2. Aaron's (AAN) upgraded to Buy from Hold at Loop Capital with analyst Anthony Chukumba saying he remains "impressed" by Progressive's revenue growth and thinks the unit will benefit from Rent-A-Center's (RCII) "ongoing struggles." 3. Cirrus Logic (CRUS) upgraded to Buy from Hold at Craig-Hallum with analyst Anthony Stoss saying he believes Apple (AAPL) headwinds are already priced into the stock and a relief rally is likely following the company's upcoming earnings this Wednesday. 4. Ventas (VTR) upgraded to Market Perform from Underperform at BMO Capital with John Kim citing a more attractive valuation after the stock price came down another 19% in 2018. 5. New York Times (NYT) upgraded to Overweight from Neutral at JPMorgan with analyst Alexia Quadrani saying she believes digital demand will likely drive further "outsized growth" for New York Times. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
EXPE Expedia
$133.73

-0.77 (-0.57%)

07/27/18
KEYB
07/27/18
NO CHANGE
Target $165
KEYB
Overweight
Expedia price target raised to $165 from $140 at KeyBanc
KeyBanc analyst Brad Erickson raised his price target on Expedia to $165 from $140 and said he remains a buyer following the company's "solid" quarterly results. In a research note to investors, Erickson says "good enough" room-night growth as well as better spending controls should continue to drive relief in the shares, and that he believes room-night acceleration in 2H remains "underappreciated."
07/27/18
07/27/18
UPGRADE
Target $157

Outperform
Expedia upgraded to Outperform on expected EBITDA growth at Raymond James
As previously reported, Raymond James upgraded Expedia to Outperform from Market Perform with a $157 price target. Analyst Justin Patterson believes the worst of the investment cycle is over and 15%+ EBITDA growth is achievable, sees hotel share gains from investments, HomeAway is making progress with the instant booking shift, and share gains and double digit EBITDA growth historically drive share outperformance.
07/27/18
DADA
07/27/18
NO CHANGE
Target $160
DADA
Buy
Expedia price target raised to $160 from $140 at DA Davidson
DA Davidson analyst Tom White raised his price target on Expedia to $160 and kept his Buy rating after its "big" Q2 EBITDA beat as a result of a "cool-down" in the ad market. The analyst notes that the quarter saw slowing room night growth to 12% from 15% in Q1, while HomeAway bookings also "slowed somewhat surprisingly" to 33% from 46%, but believes that the industry advertising "detente" with Booking Holdings (BKNG) should allow Expedia to invest in key initiatives that should pay off in 2019.
09/12/18
SBSH
09/12/18
NO CHANGE
SBSH
Amazon remains Citi's top pick in U.S. Internet
Citi analyst Mark May keeps Amazon.com (AMZN) as his top pick in U.S. Internet based on recent data points pertaining to company fundamentals, the near-term setup, recent stock performance, investor sentiment and changes since his last update. Alphabet (GOOG, GOOGL), Yelp (YELP), Expedia (EXPE), GrubHub (GRUB) and GoDaddy (GDDY) moved up in his rankings while Facebook (FB), eBay (EBAY), Twitter (TWTR), TripAdvisor (TRIP) and Booking Holdings (BKNG) moved down.

TODAY'S FREE FLY STORIES

OAS

Oasis Petroleum

$12.39

0.415 (3.47%)

05:21
10/15/18
10/15
05:21
10/15/18
05:21
Upgrade
Oasis Petroleum rating change  »

Oasis Petroleum upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$0.40

0.05 (14.28%)

05:20
10/15/18
10/15
05:20
10/15/18
05:20
Hot Stocks
Sears CEO Edward Lampert steps down as CEO, board creates 'Office of the CEO' »

Edward Lampert has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$0.40

0.05 (14.28%)

05:18
10/15/18
10/15
05:18
10/15/18
05:18
Hot Stocks
Sears files voluntary petitions for relief under Chapter 11 Bankruptcy »

Sears Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$18.20

0.85 (4.90%)

, AGIO

Agios Pharmaceuticals

$65.89

2.51 (3.96%)

05:18
10/15/18
10/15
05:18
10/15/18
05:18
Recommendations
Adamas Pharmaceuticals, Agios Pharmaceuticals, Alnylam, Alexion, Bluebird Bio, BioMarin, CymaBay, Crispr Therapeutics, Global Blood Therapeutics, Horizon Pharma, Jazz Pharmaceuticals, Ocular Therapeutix, Rigel Pharmaceuticals, Xencor analyst commentary  »

Piper lists names to own…

ADMS

Adamas Pharmaceuticals

$18.20

0.85 (4.90%)

AGIO

Agios Pharmaceuticals

$65.89

2.51 (3.96%)

ALNY

Alnylam

$82.00

2.51 (3.16%)

ALXN

Alexion

$121.91

2.62 (2.20%)

BLUE

Bluebird Bio

$125.92

-0.81 (-0.64%)

BMRN

BioMarin

$99.60

2.28 (2.34%)

CBAY

CymaBay

$10.19

0.19 (1.90%)

CRSP

Crispr Therapeutics

$37.74

0.85 (2.30%)

GBT

Global Blood Therapeutics

$33.01

1.46 (4.63%)

HZNP

Horizon Pharma

$18.27

0.23 (1.27%)

JAZZ

Jazz Pharmaceuticals

$158.82

3.42 (2.20%)

OCUL

Ocular Therapeutix

$6.09

-0.02 (-0.33%)

RIGL

Rigel Pharmaceuticals

$3.10

0.005 (0.16%)

XNCR

Xencor

$35.08

1.04 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 07

    Nov

  • 27

    Nov

  • 01

    Dec

  • 20

    Dec

  • 28

    Dec

  • 18

    Feb

SHLD

Sears

$0.40

0.05 (14.28%)

05:16
10/15/18
10/15
05:16
10/15/18
05:16
Hot Stocks
Breaking Hot Stocks news story on Sears »

Sears CEO Edward Lampert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$0.40

0.05 (14.28%)

05:14
10/15/18
10/15
05:14
10/15/18
05:14
Hot Stocks
Breaking Hot Stocks news story on Sears »

Sears files voluntary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$61.57

1.75 (2.93%)

05:12
10/15/18
10/15
05:12
10/15/18
05:12
Recommendations
Alaska Air analyst commentary  »

Alaska Air deserves…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 27

    Nov

CTMX

CytomX Therapeutics

$15.76

0.44 (2.87%)

05:09
10/15/18
10/15
05:09
10/15/18
05:09
Initiation
CytomX Therapeutics initiated  »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPR

Tapestry

$43.81

1.13 (2.65%)

05:08
10/15/18
10/15
05:08
10/15/18
05:08
Downgrade
Tapestry rating change  »

Tapestry downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

EB

Eventbrite

$28.12

0.23 (0.82%)

05:04
10/15/18
10/15
05:04
10/15/18
05:04
Initiation
Eventbrite initiated  »

Eventbrite initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$32.66

0.31 (0.96%)

05:02
10/15/18
10/15
05:02
10/15/18
05:02
Initiation
Elanco initiated  »

Elanco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ZTS

Zoetis

$88.90

1.84 (2.11%)

04:59
10/15/18
10/15
04:59
10/15/18
04:59
Upgrade
Zoetis rating change  »

Zoetis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

KSU

Kansas City Southern

$102.56

-0.41 (-0.40%)

04:57
10/15/18
10/15
04:57
10/15/18
04:57
Upgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

04:55
10/15/18
10/15
04:55
10/15/18
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

04:55
10/15/18
10/15
04:55
10/15/18
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

REFR

Research Frontiers

$1.73

0.03 (1.76%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Research Frontiers management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

TEUM

Pareteum

$2.55

0.02 (0.79%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Pareteum management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 07

    Nov

  • 15

    Nov

IHRT

iHeartMedia

$0.00

(0.00%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Cowen TMT analyst Vitanza to hold an analyst/industry conference call »

Technology, Media and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

OKE

Oneok

$64.99

-0.24 (-0.37%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Oneok management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 31

    Oct

FDX

FedEx

$220.97

3.54 (1.63%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
FedEx management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
L3 Technologies and Harris to hold a joint conference call »

The companies hold a…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

04:55
10/15/18
10/15
04:55
10/15/18
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

NXST

Nexstar

$74.10

0.2 (0.27%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Nexstar management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 08

    Nov

  • 13

    Nov

SLDB

Solid Biosciences

$34.19

-0.15 (-0.44%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Solid Biosciences has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

GOL

Gol Linhas

$7.38

0.27 (3.80%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Gol Linhas management to meet with Buckingham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.